Patents by Inventor Pankaj Qasba

Pankaj Qasba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of megakaryocytes by the use of human mesenchymal stem cells
    Patent number: 7153500
    Abstract: The present invention is directed to hematopoietic progenitor cells isolated from a tissue specimen, such as marrow cells or peripheral blood, and to the method of co-culturing isolated hematopoietic progenitor cells with human mesenchymal stem cells to induce megakaryocyte differentiation and platelet production. In addition, hematopoietic stem cells can be genetically engineered to carry genes of interest particularly for the expression of physiologically active proteins. In the presence of mesenchymal stem cells, the transduced cells carry the new genetic material and express gene products that can be used to modulate blood disorders.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: December 26, 2006
    Assignee: Osiris Therapeutics
    Inventors: Pankaj Qasba, Mark A. Thiede
  • Production of megakaryocytes by the use of human mesenchymal stem cells
    Publication number: 20010005591
    Abstract: The present invention is directed to hematopoietic progenitor cells isolated from a tissue specimen, such as marrow cells or peripheral blood, and to the method of co-culturing isolated hematopoietic progenitor cells with human mesenchymal stem cells to induce megakaryocyte differentiation and platelet production. In addition, hematopoietic stem cells can be genetically engineered to carry genes of interest particularly for the expression of physiologically active proteins. In the presence of mesenchymal stem cells, the transduced cells carry the new genetic material and express gene products that can be used to modulate blood disorders.
    Type: Application
    Filed: February 9, 2001
    Publication date: June 28, 2001
    Applicant: Osiris Therapeutics, Inc.
    Inventors: Pankaj Qasba, Mark A. Thiede
  • Production of megakaryocytes by the use of human mesenchymal stem cells
    Patent number: 6225119
    Abstract: The present invention is directed to hematopoietic progenitor cells isolated from a tissue specimen, such as marrow cells or peripheral blood, and to the method of co-culturing isolated hematopoietic progenitor cells with human mesenchymal stem cells to induce megakaryocyte differentiation and platelet production. In addition, hematopoietic stem cells can be genetically engineered to carry genes of interest particularly for the expression of physiologically active proteins. In the presence of mesenchymal stem cells, the transduced cells carry the new genetic material and express gene products that can be used to modulate blood disorders.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: May 1, 2001
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Pankaj Qasba, Mark A. Thiede